Needle-Free Flu Protection for Children and Adolescents
Needle-Free Flu Protection for Children and Adolescents
In 2026, families in New South Wales will have access to a needle-free influenza (flu) vaccine for young children.
The intranasal FluMist nasal spray vaccine will be free for children aged 2 to under 5 years. It will also be available privately for children and teens up to 18 years of age. FluMist will allow parents to protect their young children from severe flu without the stress of a needle, as it is delivered via a painless and simple nasal spray.
Why is it important to vaccinate my child for the flu?
Although flu can be mild for some, it can also cause serious illness and hospitalisation, even in healthy children. Vaccination helps protect them from severe disease and reduces community spread, helping keep vulnerable people safer.
How does it work?
FluMist is a live-attenuated vaccine, meaning that it contains weakened strains of flu viruses that train the immune system to recognise the viruses. but cannot cause illness in healthy individuals.
It is given as a quick spray into each nostril and is rapidly absorbed. If a child sneezes or blows their nose afterwards, the vaccine will still work and does not need to be repeated.
Common side effects are mild and short-lived, such as a runny nose or other mild respiratory symptoms. The vaccine is not suitable for children who are moderately or severely immunocompromised and should be used with caution for those who are close contacts of people with significant immunocompromise.
Where can my child get the intranasal vaccine?
The intranasal vaccine will be available for free at the GP for children aged two to under five and can be purchased privately for children aged five to under eighteen at GPs and certain pharmacies.
Find out more information about the intranasal flu vaccine in the National Centre for Immunisation Research and Surveillance (NCIRS) Frequently Asked Questions resource.
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Measles alert for Campbelltown area COVID-19 vaccines now funded through the NIP New NIP schedule COVID-19 vaccine ordering now open Updates to the Australian Immunisation Handbook Education Measles alert for Campbelltown area Healthcare providers are…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Measles alert: Ensure patients are travel ready CESPHN webinar: Immunisation without borders MenB Remains Leading Cause of Invasive Meningococcal Disease in Australia Education Measles Alert: Ensure Patients Are Travel-Ready Healthcare providers are reminded to use…
New universal antenatal syphilis screen introduced at 36 weeks gestation NSW Health has updated the Policy Directive Syphilis in Pregnancy and Newborns (PD2026_044) to strengthen the prevention of congenital syphilis and align with the updated Australian Pregnancy Care Guidelines. Under the revised Policy Directive, syphilis screening should be offered to…
SESLHD State-Wide Referral Criteria (SRC) SESLHD is preparing to implement the next phase of the NSW Statewide Referral Criteria (SRC) for referrals to public hospital outpatient services. The SRC establishes consistent clinical referral requirements across NSW, helping general practitioners and other referrers to: Determine when referral to a public outpatient…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar COVID-19 vaccine stock RSV now Australia’s most notified respiratory virus: a timely reminder to check vaccine status Education COVID-19 vaccination…
New NSW medicines and poisons legislation commences 5 November 2026 New NSW medicines and poisons legislation will commence on 5 November 2026, replacing the current regulatory framework with the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026. The changes introduce new requirements…